Search Results - "Monberg, Matthew J" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

Randomized Phase III Trial of Gemcitabine-Based Chemotherapy With In Situ RRM1 and ERCC1 Protein Levels for Response Prediction in Non–Small-Cell Lung Cancer

by Reynolds, Craig, Obasaju, Coleman, Schell, Michael J, Li, Xueli, Zheng, Zhong, Boulware, David, Caton, John R, Demarco, Linda C, O'Rourke, Mark A, Shaw Wright, Gail, Boehm, Kristi A, Asmar, Lina, Bromund, Jane, Peng, Guangbin, Monberg, Matthew J, Bepler, Gerold
Published in Journal of clinical oncology (01.12.2009)

Get full text

Journal Article

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

by SOCINSKI, Mark A, WEISSMAN, Charles, HART, Lowell L, BECK, J. Thaddeus, CHOKSI, Janak K, HANSON, John P, PRAGER, Diane, MONBERG, Matthew J, ZHISHEN YE, OBASAJU, Coleman K
Published in Journal of clinical oncology (20.10.2006)

Get full text

Journal Article

Prognosis and conditional survival among women with newly diagnosed ovarian cancer

Prognosis and conditional survival among women with newly diagnosed ovarian cancer

by Szamreta, Elizabeth A., Monberg, Matthew J., Desai, Kaushal D., Li, Yeran, Othus, Megan
Published in Gynecologic oncology (01.01.2024)

Get full text

Journal Article

Venous and arterial thromboembolism in severe sepsis

Venous and arterial thromboembolism in severe sepsis

by Levine, Robert L, LeClerc, Jacques R, Bailey, Joan E, Monberg, Matthew J, Sarwat, Samiha
Published in Thrombosis and haemostasis (01.05.2008)

Get more information

Journal Article

Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial

Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial

by Monk, Bradley J, Tewari, Krishnansu S, Dubot, Coraline, Caceres, M Valeria, Hasegawa, Kosei, Shapira-Frommer, Ronnie, Salman, Pamela, Yañez, Eduardo, Gümüş, Mahmut, Hurtado de Mendoza, Mivael Olivera, Samouëlian, Vanessa, Castonguay, Vincent, Arkhipov, Alexander, Tekin, Cumhur, Li, Kan, Martin Nguyen, Allison, Monberg, Matthew J, Colombo, Nicoletta, Lorusso, Domenica
Published in The lancet oncology (01.04.2023)

Get full text

Journal Article

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer

by Movsas, Benjamin, Langer, Corey J., Ross, Helen J., Wang, Luhua, Jotte, Robert M., Feigenberg, Steve, Xu, Feng, Huang, Chao H., Monberg, Matthew J., Obasaju, Coleman K.
Published in Journal of thoracic oncology (01.05.2010)

Get full text

Journal Article

Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology Clinics

Comparison of advanced ovarian cancer patients treated with or without bevacizumab in the US Community Oncology Clinics

by DeClue, Richard W, Szamreta, Elizabeth A, Gautam, Santosh, Fisher, Maxine D, Monberg, Matthew J
Published in Future oncology (London, England) (01.05.2023)

Get full text

Journal Article

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers

A Narrative Review of the Clinical, Humanistic, and Economic Value of Pembrolizumab-Based Immunotherapy for the Treatment of Breast and Gynecologic Cancers

by Monberg, Matthew J, Keefe, Steve, Karantza, Vassiliki, Tryfonidis, Konstantinos, Toker, Sarper, Mejia, Jaime, Orlowski, Robert, Haiderali, Amin, Prabhu, Vimalanand S, Aktan, Gursel
Published in Oncology and therapy (25.10.2024)

Get full text

Journal Article

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

Comparison of pemetrexed plus cisplatin with other first-line doublets in advanced non-small cell lung cancer (NSCLC): A combined analysis of three phase 3 trials

by Treat, Joseph, Scagliotti, Giorgio V, Peng, Guangbin, Monberg, Matthew J, Obasaju, Coleman K, Socinski, Mark A
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2012)

Get full text

Journal Article

A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer

A retrospective analysis of outcomes by age in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel vs. paclitaxel plus carboplatin for advanced non-small cell lung cancer

by Ansari, Rafat H, Socinski, Mark A, Edelman, Martin J, Belani, Chandra P, Gonin, René, Catalano, Robert B, Marinucci, Donna M, Comis, Robert L, Obasaju, Coleman K, Chen, Ruqin, Monberg, Matthew J, Treat, Joseph
Published in Critical reviews in oncology/hematology (01.05.2011)

Get full text

Journal Article

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program

by Jänne, Pasi A., Wozniak, Antoinette J., Belani, Chandra P., Keohan, Mary-Louise, Ross, Helen J., Polikoff, Jonathan A., Mintzer, David M., Taylor, Loretta, Ashland, Joseph, Ye, Zhishen, Monberg, Matthew J., Obasaju, Coleman K.
Published in Clinical lung cancer (01.07.2005)

Get full text

Journal Article

Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

by Edelman, Martin J., Belani, Chandra P., Socinski, Mark A., Ansari, Rafat H., Obasaju, Coleman K., Chen, Ruqin, Monberg, Matthew J., Treat, Joseph
Published in Journal of thoracic oncology (01.01.2010)

Get full text

Journal Article

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancer

by Treat, Joseph, Edelman, Martin J, Belani, Chandra P, Socinski, Mark A, Monberg, Matthew J, Chen, Ruqin, Obasaju, Coleman K
Published in Lung cancer (Amsterdam, Netherlands) (01.12.2010)

Get full text

Journal Article

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

by Jänne, Pasi A., Wozniak, Antoinette J., Belani, Chandra P., Keohan, Mary-Louise, Ross, Helen J., Polikoff, Jonathan A., Mintzer, David M., Ye, Zhishen, Monberg, Matthew J., Obasaju, Coleman K.
Published in Journal of thoracic oncology (01.07.2006)

Get full text

Journal Article

Efficacy and safety of pemetrexed in elderly cancer patients: Results of an integrated analysis

Efficacy and safety of pemetrexed in elderly cancer patients: Results of an integrated analysis

by Kulkarni, Pandurang M, Chen, Ruqin, Anand, Taruna, Monberg, Matthew J, Obasaju, Coleman K
Published in Critical reviews in oncology/hematology (01.07.2008)

Get full text

Journal Article

Review of oxymetholone: a 17α-alkylated anabolic-androgenic steroid

Review of oxymetholone: a 17α-alkylated anabolic-androgenic steroid

by Pavlatos, Andrew M., Fultz, Oliver, Monberg, Matthew J., Vootkur, Anil
Published in Clinical therapeutics (01.06.2001)

Get full text

Journal Article

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

by Gralla, Richard J., Edelman, Martin J., Detterbeck, Frank C., Jahan, Thierry M., Loesch, David M., Limentani, Steven A., Govindan, Ramaswamy, Peng, Guangbin, Monberg, Matthew J., Obasaju, Coleman K., Socinski, Mark A.
Published in Supportive care in cancer (01.03.2009)

Get full text

Journal Article

Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology

Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology

by Zinner, Ralph G, Saxman, Scott B, Peng, Guangbin, Monberg, Matthew J, Ortuzar, Waldo I
Published in Clinical lung cancer (01.09.2010)

Get full text

Journal Article

A Comparison of White and African American Outcomes from a Three-Arm, Randomized, Phase III Multicenter Trial of Advanced or Metastatic Non-small Cell Lung Cancer

A Comparison of White and African American Outcomes from a Three-Arm, Randomized, Phase III Multicenter Trial of Advanced or Metastatic Non-small Cell Lung Cancer

by Obasaju, Coleman K., Ansari, Rafat H., Socinski, Mark A., Chen, Ruqin, Monberg, Matthew J., Catalano, Robert B., Marinucci, Donna M., Liles, Darla K., Ribeiro, Maria-Jose, Comis, Robert L., Treat, Joseph
Published in Journal of thoracic oncology (01.07.2010)

Get full text

Journal Article

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

by Obasaju, Coleman K, Ye, Zhishen, Wozniak, Antoinette J, Belani, Chandra P, Keohan, Mary-Louise, Ross, Helen J, Polikoff, Jonathan A, Mintzer, David M, Monberg, Matthew J, Jänne, Pasi A
Published in Lung cancer (Amsterdam, Netherlands) (01.02.2007)

Get full text

Journal Article